# Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria

> **NCT00331136** · PHASE2 · COMPLETED · sponsor: **Medicines for Malaria Venture** · enrollment: 60 (actual)

## Conditions studied

- Uncomplicated Plasmodium Falciparum Malaria

## Interventions

- **DRUG:** Pyronaridine-Artesunate

## Key facts

- **NCT ID:** NCT00331136
- **Lead sponsor:** Medicines for Malaria Venture
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-05-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331136, "Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00331136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*